Skip to main content
OpenTrials

Clinical trial condition

Acute Lymphoblastic Leukemia, in Relapse

Explore clinical trials studying Acute Lymphoblastic Leukemia, in Relapse. Study availability and eligibility vary by location and protocol.

27 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Acute Lymphoblastic Leukemia, in Relapse trial results

Recruiting

Determining the Mechanisms of Loss of CAR T Cell Persistence

NCT05809284

Conditions
Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, Adult, +13 more
Locations
  • Great Ormond Street Hospital London, United Kingdom
  • University College London Hospital London, United Kingdom
  • Royal Manchester Children's Hospital Manchester, United Kingdom
View Trial Details
Recruiting

Venetoclax Basket Trial for High Risk Hematologic Malignancies

NCT05292664

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Leukemia of Ambiguous Lineage in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, +28 more
Locations
  • University of California San Francisco-Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital Atlanta, Georgia, United States
  • Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

NCT06316856

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details
Recruiting

Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

NCT06316427

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details
Recruiting

A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies

NCT07070323

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details

Related conditions